REQUEST A DEMO
Total
USD $0.00
Search more companies

Ibn Sina-Med Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Ibn Sina-Med Sp. z o.o. Profile Updated: October 20, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Ibn Sina-Med Sp. z o.o. is a company based in Poland, with its head office in Dzierzoniow. It operates in the Ambulatory Health Care Services industry. The company was established on July 03, 2019. The latest financial highlights indicate a net sales revenue drop of 2.93% in 2022. There was a total growth of 313.27% in Ibn Sina-Med Sp. z o.o.’s total assets over the same period. In 2022, Ibn Sina-Med Sp. z o.o.’s net profit margin increased by 25.76%.

Headquarters
Ul. Parkowa 4A
Dzierzoniow; Dolnoslaskie; Postal Code: 58-200

Contact Details: Purchase the Ibn Sina-Med Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ibn Sina-Med Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ibn Sina-Med Sp. z o.o. report to view the information.
Incorporation Date:
July 03, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
98%
Company Performance
Financial values in the chart are available after Ibn Sina-Med Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-2.93%
Total operating revenue
-2.81%
Operating profit (EBIT)
1003.92%
Net Profit (Loss) for the Period
996.84%
Total assets
313.27%
Total equity
438.72%
Operating Profit Margin (ROS)
28.33%
Net Profit Margin
25.76%
Return on Equity (ROE)
41.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?